EA Series Trust’s Boston Scientific BSX Stock Holding History

EA Series Trust’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$1.35M	Buy	+24,972	New	+$1.3M	0.05%	528

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

EA Series Trust's BSX Position: Q2 2023 in Review

EA Series Trust opened a new position in Boston Scientific (BSX) in Q2 2023: 24,972 shares worth $1.35M. The stake represents 0.05% of the portfolio and ranks #528 among its holdings.

1,066 funds tracked by Wall St. Rank hold BSX as of Q2 2023.

EA Series Trust held 24,972 shares of Boston Scientific worth $1.35M as of Q2 2023.
Boston Scientific was a new EA Series Trust position in Q2 2023.
Boston Scientific made up 0.05% of EA Series Trust's portfolio in Q2 2023, its #528 holding.
1,066 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2023.

Based on EA Series Trust's 13F filing for Q2 2023, filed 27 Jul 2023.